Gregory Grabowski, MD, discusses the use of whole genome sequencing and artificial intelligence (AI) in epigenetics and epigenomics.
Epigenetics and epigenomics provide critical insights into why family members with the same disease may exhibit distinct clinical presentations. These differences are influenced by variations in gene mutations and modifications. Recent technological advancements, including whole genome sequencing and artificial intelligence, have significantly enhanced the ability to analyze and interpret this complex data, paving the way for more personalized and precise approaches to healthcare.
For more information on the GRIDS Symposium, click here.
To learn more about rare lysosomal storage diseases, visit https://checkrare.com/diseases/lysosomal-storage-disorders/
